Drug Clinical Trials List

Display 101 - 110 from 730

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
A Real-World Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Patients Receiving Dupilumab Therapy, with Atopic Dermatitis Control Tool in Gulf Countries	Sanofi	Ongoing	Dupilumab (Dupixent)	4	OBS17399	King Abdulaziz University Hospital (Jeddah),Saudi Airlines Medical Service Center,Dr. Erfan & Bagedo General Hospital (Jeddah),Specialized Medical Center (Riyadh),JC Clinics Complex – Jeddah,Saudi German Hospital (Jeddah),Sulaiman Al Habib Hospital - Al Khobar,King Fahad Medical City (Riyadh),King Faisal General Hospital (Makkah),Al Mana Hospital,King Abdul Aziz Hospital (Makkah)
A Phase 3 Open-label Trial of Neoadjuvant Trastuzumab Deruxtecan (T-DXd) Monotherapy or T-DXd followed by THP Compared to ddAC-THP in Participants with High-risk HER2-positive Early-stage Breast Cancer (DESTINY-Breast11)	Astrazeneca	Ongoing	Trastuzumab-deruxtecan	3	D967RC00001	International Medical Center (Jeddah),King Fahad Specialist Hospital (Dammam)
Evaluation Of Use of Belimumab in Clinical Practice SEttings (OBSErve): Observations from a retrospective, observational study on patients with SLE in Russia and Saudi Arabia	GSK	Ongoing	Belimumab	4	OneCDP 215	King Fahad Medical City (Riyadh),Aseer Central Hospital (Abha),King Khalid University Hospital (Riyadh),King Fahad specialized hospital (Tabuk)
The Effect of Synbiotic Consumption on Glycemic, Inflammatory Markers and Body Composition on Prediabetic and Diabetic Patients: A Double Blinded Randomized Control Trial	Imam Abdulrahman Bin Faisal University	Ongoing	Synbiotics (Viridian Nutrition)	3	IRB-2019-03-227	King Fahad University Hospital (Al-Khobar) , Family and Community Medicine Center (Dammam)
ABROCITINIB EXPANDED ACCESS PROTOCOL FOR THE TREATMENT OF ADOLESCENTS AND ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS	Pfizer	Terminated	Abrocitinib	3	B7451064	King Abdulaziz University Hospital (Jeddah)
A randomized, double-blind, placebo controlled study assessing the long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate to severe asthma	Sanofi Aventis	Ongoing	Dupilumab	4	LPS16676	King Saud Medical City (Riyadh),King Abdullah Medical City (Makkah)
Effectiveness of Dextrose 5% In Water Local Injection Into Spastic Muscles to manage focal Spasticity (D5W/ Spasticity ).	PI-initiated	Rejected	DEXTROSE 5% IN WATER	4	TU022144	King Fahad specialized hospital (Tabuk)
The effects of alpha lipoic acid supplementation on nerve conduction study in patients with diabetic neuropathy	EVA PHARMA	Rejected	ALPHA LIPOIC ACID	4	IRB-2022-5	King Fahad University Hospital (Al-Khobar)
Transthyretin Amyloidosis Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey of Patients With Documented Transthyretin Gene Mutations or Wild-Type Transthyretin Amyloidosis	Pfizer	Terminated	Tafamidis	4	B3461001	King Faisal Specialist Hospital and Research Center (Riyadh)
A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease	Agios Pharmaceuticals, Inc.	Ongoing	Mitapivat	2/3	AG348-C-020	King Khalid University Hospital (Riyadh)